Statements (15)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Dirk_Thye
|
gptkbp:country |
gptkb:United_States
|
gptkbp:focusesOn |
rare diseases
precision therapeutics |
gptkbp:formerName |
gptkb:Cortexyme,_Inc.
|
gptkbp:foundedYear |
2012
|
gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Quince Therapeutics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:tradedOn |
gptkb:NASDAQ:_QNCX
|
gptkbp:website |
https://www.quincetx.com/
|
gptkbp:bfsParent |
gptkb:Cortexyme
|
gptkbp:bfsLayer |
7
|